thoracic surgery description of service 2007
TRANSCRIPT
Cardiothoracic Centre
Swansea NHS Trust
Thoracic Surgery
Description of Service 2007
Executive Summary 4
Introduction 5
Background to the Swansea Service 6
Health Commission Wales (HCW) Aims and Objectives 7
For thoracic surgical services HCW aims 7
Descriptions of the relevant associated services within Swansea NHS Trust 8
Respiratory medicine 8
Video-Assisted Thoracic Surgery. 8
Endobronchial therapies 8
Cardiac surgery 8
Cardiothoracic anaesthesia and intensive care 9
Radiology 9
Plastic and Reconstructive surgery 9
Ear, Nose and Throat (ENT) surgery 10
Trauma services 10
Oesophageal disease 11
Radiotherapy & Chemotherapy 11
Palliative care 11
All Wales minimum standards 12
Description of the range of thoracic procedures offered by Swansea NHS Trust 13
Description of facilities for thoracic surgery 13
Description of MDT arrangements for lung cancer care in South West Wales 13
Moving towards a Managed Network 14
Activity Data 15
Thoracic Surgical procedures 2006-2007 15
Current activity compared with historical activity 16
Complications following thoracic surgery 16
Average and Median Length of stay 16
Mortality 16
Predicted future demand modelling 18
Assumptions 18
New scanning techniques 18
Theatre/bed capacity in cardiothoracic centre 19
Appointment of a second Consultant Thoracic Surgeon 20
Benefi ts of appointment 20
Conclusions 21
Thoracic Surgery Satisfaction Surveys 22
Glossary 25
Con
tent
s
4
Executive Summary
1. Thoracic surgery based at Morriston Hospital ensures that high quality, best value spe-
cialised treatment is provided close to patients’ homes.
2. Morriston Hospital is geographically placed in the centre of South Wales with travel
times from the west (Haverfordwest) and east (Chepstow) being 80 minutes. This im-
proves equity of access and allows the needs of patients, their families and friends to be
at the forefront of the service.
3. Morriston Hospital has the key components of lung cancer services (i.e.
respiratory physicians, thoracic surgeons, thoracic radiology, thoracic histo-
pathologist, oncology, and palliative care) already established on one site. Patients and
clinical staff are closer to the facilities and the multidisciplinary team.
4. Thoracic surgery and anaesthesia at Morriston Hospital provide support to
Respiratory Physicians in their management of non-malignant chest diseases as well as
procedures uniquely performed at Morriston Hospital such as endo-
bronchial stenting, laser, diathermy and photodynamic therapies.
5. Thoracic surgery provides support to other local and regional specialist services within
the Trust such as trauma, maxillofacial, oesophageal, plastic and ENT surgery and sup-
ports the wider activities of the Swansea Cancer centre (e.g. diagnosis and staging of lym-
phoma)
6. Education and training are important activities of the Trust and the School of Medicine,
Swansea. Thoracic surgery is an important component of undergraduate and postgradu-
ate training. Specialist Registrars in Respiratory medicine are uniquely placed to witness
the management of complex respiratory problems by medical and surgical means.
Morriston Hospital, Swansea
IntroductionThoracic Surgery is a specialty focusing on
the diagnosis and surgical treatment of disorders
of the chest that encompasses a wide range of
procedures pertaining to the chest, but exclud-
ing the heart. It includes surgery to the lung,
mediastinum, chest wall (including reconstruc-
tion) biopsies and excision of lung and pleura for
malignant and non-malignant conditions together
with miscellaneous other non-cardiac procedures.
In the UK, 60% of these surgical procedures are
performed by cardiothoracic surgeons (who also
perform operations on the heart) while 40%
are conducted by standalone thoracic surgeons.
About 50% of the work of a thoracic surgeon
is spent dealing with surgical resections of lung
cancers and other malignant diseases of the chest.
South Wales has a legacy of heavy industry and
coal mining, both of which contribute signifi cantly
to lung disease. Lung cancer is the commonest
cause of cancer death in
Wales. Tobacco smoking
has been shown to ac-
count for about 80-90%
of all cases in men and
50-80% in women. The
median overall survival
in the UK is between 4
and 6 months with an
overall 5-year survival
of <10%. The 5-year
survival in those under-
going curative resection
is 35-60% depending
on the histological type and stage of tumour. The
population of Wales has a poor survival rate for
lung cancer compared to the UK, the rest of
Europe and the USA. Surgery is the only known
cure for lung cancer, suggesting that there is a low
curative resection rate for lung cancer in Wales.
Delays in diagnosis, staging and access to surgical
resection may all contribute to this poor outcome.
Thoracic surgeons also treat non-malignant condi-
tions that are referred by respiratory physicians
such as complications of pneumonia, treatment
of air leaks from the lungs into the chest cavity,
drainage of fl uid from the lung cavities, biopsy of
infl ammed lung tissue, surgical repair of benign
narrowing of the windpipe and interruption of
specifi c nerves for severe sweating. Thoracic
surgeons also treat non-malignant tumours of the
lungs and chest wall. In addition, congenital chest
wall abnormalities are very common in the United
Kingdom. Pectus excavatum affects 1 in 500 of
the population (i.e. in South Wales alone there are
4600 cases). Many of these require surgical cor-
rection for symptomatic or psychological reasons.
Morriston Hospital in Swansea is the largest of the
acute hospitals in South West Wales and houses
many regional and specialised tertiary
services. Morriston Hospital is located
just over 1 mile from junction 46 of the
M4 motorway and is thus very acces-
sible being positioned in the middle of
South Wales and having travel times of
only 80 minutes to Haverfordwest in
the west and Chepstow in the east.
5
Background to the Swansea Service
During the commissioning of the Cardiac Centre
in the mid 1990s, the chest physicians in South
West Wales, through the Local Health Authori-
ties, approached the then Morriston Hospital
NHS Trust seeking the development of a thoracic
surgical service within the new Cardiac Centre.
Following a survey in 1996 to establish the need
for the services that was conducted by Dr Kim
Harrison and the Trust management, the Trust
agreed with the Health Authorities to provide
the service on a cost-per-case basis until proper
facilities for thoracic surgery were established.
In June 1997, Dr Gill Todd (Chief Executive of Bro
Taf Health Authority, representing all 3 Health
Authorities in South Wales) set up and chaired
the thoracic strategy group for South Wales (fi rst
review). This group had representatives from
all stakeholders of the services including two
external advisors from the Society of Cardiot-
horacic Surgeons of Great Britain and Ireland,
namely Professor Tom Treasure and Mr John
Dark. This group advised and concluded that the
service should be provided both in Cardiff and
in Swansea and that Thoracic Surgery at Lland-
ough Hospital should be moved to the University
Hospital of Wales within the Cardiac Centre.
The cardiothoracic surgeons began to offer tho-
racic surgery on a “case-by-case” basis thereafter.
Over subsequent years, as the volume of work
increased, it was clear that cardiac surgical capac-
ity was being compromised as a consequence of
thoracic surgical activity. Furthermore, lack of
resources made it diffi cult to meet All Wales
Minimum Standards for timely lung cancer
resection. Therefore, a decision was made
to suspend the service temporarily (despite
the demand) until it was resourced appropri-
ately with provision of dedicated facilities.
A second review of thoracic surgical services was
commissioned in 2002 but the report was not
published. After the input of dedicated funds by
Health Commission Wales, the thoracic surgical
service recommenced in March 2004. Additional
beds were ring-fenced on Morriston Hospital’s
ward S and theatre space and high dependency
beds arising out of the phase I (cardiac surgi-
cal) upsizing of the Cardiac Centre were al-
located to the service. Three of the in-house
cardiothoracic surgeons provided additional
sessions to cover the Thoracic Surgical activity.
In July 2005, the Thoracic beds were relocated
from Ward S into the main Cardiac Centre as
a result of space vacated by the move of the
cardiology day-case unit in the Cardiac Centre
(Phase II of upsizing). Nursing care is now de-
livered by cardiothoracic nursing staff based on
Cyril Evans ward leading to economies of scale.
6
Health Commission Wales (HCW)
Aims and Objectives
The HCW website states:
The primary objective of Health Commis-
sion Wales (Specialist Services) is to en-
sure that Wales derives the maximum pos-
sible benefi t from the Specialist Services
Commissioning and, in particular to:
1) Secure an appropriate range
of high quality, best value
specialised services for the
people of Wales within an
agreed budget
2) Place the needs of patients,
their families and friends and
the public at the forefront of
HCW(SS) business
3) Develop effective partner-
ships with all key stakehold-
ers
4) Ensure effective com-
missioning processes are
consistent with NHSWD
targets, priorities and objec-
tives and with LHB commis-
sioning
5) Ensure equity of access
6) Ensure the customer focus
of operational
processes
For thoracic surgical services HCW aims
“To provide an integrated, audited, safe, high
quality, sustainable thoracic surgery serv-
ice to the residents of South Wales that:
• Meets relevant national and
international standards;
• Has the potential and fl exibil-
ity to meet all the present and
future needs (including currently
unmet needs) and requirements;
• Is provided by skilled, account-
able professionals (working in
MDTs) as close to the patient’s
home as possible.
• Is adequately resourced”.
7
Descriptions of the relevant associated services within Swansea NHS Trust
Respiratory medicine
The Department of Respiratory Medicine pro-
vides clinical services at Morriston and Singleton
Hospitals. There are 2 consultant physicians based
at Morriston Hospital (Dr Kim Harrison and Dr
Emrys Evans) and 3 based at Singleton Hospi-
tal (Dr Phil Ebden, Dr Stuart Packham and Prof.
Julian Hopkin). They diagnose and treat common
conditions such as lung cancer, asthma, bronchitis,
emphysema and pneumonia as well as less com-
mon conditions such as tuberculosis, occupational
lung diseases and sleep disordered breathing. The
Respiratory Physicians co-ordinate the multidisci-
plinary team for treating patients with lung cancer.
Diffuse parenchymal lung disease (DPLD) is one
of several disease groups that the Welsh Assembly
Government has identifi ed as requiring guidelines
for management through the Respiratory Imple-
mentation Group. It recommended that patients
with DPLDs should have access to Regional
Centres where diffi cult cases can be discussed and
the requirement for surgical lung biopsy consid-
ered (as demonstrated by a survey conducted
by Dr Kim Harrison in 2002). This is likely to
increase the number of surgical biopsies that are
undertaken in Wales by approximately two-fold.
Video-Assisted Thoracic Surgery.
Video-assisted tho-
racic surgery (VATS)
is a minimally invasive
technique that has
been used routinely
by the cardiotho-
racic unit since it
opened in 1997. It is used for the treatment
of pneumothorax, pleural procedures includ-
ing pleurodesis and surgical lung biopsies. VATS
reduces morbidity (especially pain) and thus
length of hospital stay leading to cost-effi ciencies.
Endobronchial therapies
Morriston Hospital is the only centre in Wales
to provide an extensive range of therapies
such as endobronchial stenting, laser, dia-
thermy and photodynamic treatment. These
are undertaken by the Respiratory Physicians
at Morriston through on-site support of the
cardiothoracic surgeons and anaesthetists.
Cardiac surgery
Cardiac Surgery is based in the Cardiac Centre
at Morriston Hospital. There are 2 dedicated
cardiothoracic theatres, 8 Intensive care beds, 8
High Dependency beds and 20 ward beds. The
unit undertakes all types of adult cardiac surgery
including major surgery on the thoracic aorta but
does not undertake complex congenital heart
disease or transplant surgery. Annual activity
is 750 – 800 cardiac surgical procedures. The
Cardiac Centre has some of the best outcomes
in the UK for fi rst-time coronary artery by-pass
surgery and aortic valve surgery over many years
(http://heartsurgery.healthcarecommission.org.uk).
All 5 consultant cardiothoracic surgeons in the
unit are fully trained in both cardiac and thoracic
surgery. All nursing and support staff are trained
to manage thoracic surgical patients. The presence
of thoracic surgery on-site has undoubtedly helped
recruitment and retention of staff within the unit.
8
Cardiothoracic anaesthesia and intensive care
There are 5 Consultant Cardiothoracic Anaes-
thetists in the Cardiac Centre who provide
theatre sessions and cover for the 8-bed-
ded Cardiothoracic Intensive Care unit.
Additional appointments are currently being made.
The existing consultant cardiothoracic
anaesthetists are fully trained in cardiac
and thoracic anaesthesia. Many see the
attraction of the post in the unit as the mix
of both cardiac and thoracic surgery.
In April 2007, the Car-
diac Intensive Care Unit
was re-accredited as a
Practice Development
Unit following review by the University of
Leeds. The reviewers met with a number of
patients and made the following comments:
“Patients on the unit spoke movingly and
powerfully of the effect that the team had
had upon their lives, and others were patient
representatives from the wider Trust who
clearly enjoyed working with the team.”
“The range of presentations demonstrated
clearly the multi-disciplinary nature of the
practice development unit and how effectively
the various disciplines worked together.”
All the presentations had patients, their experi-
ences and their outcomes as crucial components.”
“This is absolutely not a team that pays lip serv-
ice to the notion of patient centredness.”
“We were also pleased to hear of the
close and collaborative relationships
that the team have developed with col-
leagues in the University of Swansea.”
Radiology
The Department of
Radiology houses a wide
range of imaging facili-
ties including spiral multi-array X-ray computed
tomography (CT), Magnetic Resonance Imaging,
ultrasound, Digital Subtraction angiography and
gamma camera imaging. Dr David Roberts, Dr
Liam McKnight and Dr Derrian Markham provide
on-site expertise in chest radiology. Following
an agreed investigation and treatment strategy at
the MDT meeting, they undertake endoscopic-,
CT- and ultrasound-guided fi ne needle aspira-
tions and biopsies on behalf of the team. The
Respiratory Physicians also undertake diagnostic
trans-bronchial needle aspiration based on CT
imaging. . In addition, a new 3 Tesla MRI scanner is
currently being commissioned at Singleton Hospi-
tal to increase imaging capacity within the Trust.
Plastic and Recon-
structive surgery
The Welsh Centre
for Burns and Plastic Surgery was transferred
from St. Lawrence Hospital Chepstow to Mor-
riston in 1994 in order to be at the centre of
the South Wales catchment area and to benefi t
from the presence of other services in Swansea.
Plastic surgeons are able to carry out complex
reconstructions of the chest wall for trauma and
malignant disease (e.g. invasive breast cancers, soft
tissue sarcomata) in combination with thoracic
surgery colleagues. The burns centre is expected
to be awarded Su-
pra-Regional Burns
Centre Status in the
near future and is
ranked top against
the UK standards
for burns care. One
9
component of these standards was the pres-
ence of other trauma services on site. The Welsh
service can confi dently receive burn patients
with any type of associated trauma including
thoracic injury in the knowledge that all ap-
propriate specialists are available in the Trust.
Ear, Nose and Throat (ENT) surgery
ENT surgery is based in Swansea. The tho-
racic surgeons and ENT surgeons occasion-
ally undertake joint operations for example
because a surgical resection of the larynx re-
quires mobilisation of the bronchial tree or
if a tracheal lesion such as a stricture or tu-
mour extends from the chest into the neck.
Trauma services
Morriston Hospital has emerged as the Trauma
Centre for South West Wales. Previously, a small
number of patients with severe chest injuries
would have been transferred to Cardiff for surgical
intervention. Clearly it is undesirable for patients
with major injuries who may be critically ill to be
moved when all facilities and expertise are on site.
In addition, they would
potentially be moved
away from on-site
expertise in burns,
plastic and recon-
structive surgery and
maxillofacial surgery.
Lack of emergency thoracic input in specifi c cases
would inevitably put patients at increased risk.
There are approximately 40 cases of signifi cant
thoracic trauma per year admitted to Morriston
Hospital. About 4 to 6 patients require emergency
thoracotomy, but the remainder require thoracic
surgical consultation for advice requiring the man-
agement of their injuries, the placement, manage-
ment and removal of intercostal chest drains.
Clinical outcomes following trauma are collected
by the national Trauma and Research Network
(TARN) database. Details for Wales can be found
at https://www.tarn.ac.uk/Content.aspx?c=587
The fi gures released in August 2007 showed
that Morriston Hospital has the highest number
of trauma admissions in Wales. It was the only
hospital in Wales where data on all injured pa-
tients between January 2004 and December 2005
admitted to the Trust were submitted to the
database. Trauma to the chest is one important
component of these statistics. The Royal College
of Surgeons and British Orthopaedic Association
state in their guidelines on standards of care 13.3:
“Examination of the chest is a fundamental com-
ponent of the cardiopulmonary assessment of the
seriously injured and should be supervised by the
most experienced clinician”. The TARN statistics
therefore identify the number of chest injuries
and the proportion assessed by consultants.
The fi gures reveal that survival rates in Swan-
sea are 2.1 per cent higher than expected, plac-
ing Morriston in the top 15 UK hospitals that
took part in the research. Between 2003/4 and
2005/06, Morriston admitted 943 trauma pa-
tients. According to TARN, 847 of these patients
were expected to survive, but in fact, the fi gure
was higher, at 869. Of the patients admitted with
chest injuries, 49% were assessed by consultants
(compared with the national average of 43%).
10
The table below demonstrates the comparative
data for comparable centres closest to Wales.
Morriston
Hospital,
Swansea
University
Hospital
of Wales,
Cardiff
Bristol Royal
Infi rmary and
Frenchay
Royal
Devon and
Exeter
Hospital
University
Hospital,
Birmingham
Wythenshawe
Hospital,
Manchester
Manchester
Royal Infi rmary
The Royal Liverpool
University Hospital
Additional
survivors (per
100 treated)
+2.1 0.0 No data -0.6 +0.6 -2.2 No data -1.6
Number of
chest injuries
140 110 No data 133 23 81 No data 88
Number seen
by consultant
49% 25% No data 66% 26% 43% No data 28%
Oesophageal disease
Oesophageal surgery is performed at Morris-
ton Hospital by general surgeons with a specifi c
expertise. Some surgery is performed with the
input of thoracic surgeons (e.g. trachea and
bronchus injury, empyema) and has been per-
formed collaboratively since the opening of the
Cardiac Centre in 1997. The thoracic surgeons
also provide support for general surgeons when
their patients develop pulmonary complications.
Radiotherapy & Chemotherapy
The Swansea Cancer Centre is based at Single-
ton Hospital, Swansea and has the benefi t of a
newly appointed chair of Clinical Oncology (Prof.
Taylor). Radiotherapy is offered at the Regional
Cancer Centre based at Singleton Hospital, which
has recently benefi tted from an additional linear
accelerator to improve treatment access times. A
new CT simulator is expected to be operational
during this fi nancial year and the Trust has re-
cently appointed an additional Consultant Clinical
Oncologist to support lung cancer treatment.
Improved chemotherapy regimes that successfully
downsize lung tumours will increase the number
of resectable cases. In addition, chemotherapy
for mesothelioma (which will increase in inci-
dence over the next 10-15 years) will render such
tumours more amenable to surgical resection and
modern chemothera-
pies for other malig-
nancies (e.g. bowel,
malignant melanoma)
will increase the
number of resections
required for “solitary”
11
lung secondaries. These factors will increase the
need for thoracic surgery in the future. The Trust
provides clinical leadership for sarcoma in South
Wales and the sarcoma MDT works closely with
the thoracic surgery team to ensure that biopsy
or metastatectomy is offered where appropriate.
Palliative care
The hospital and commu-
nity palliative care teams are
based in Ty Olwen, within the
grounds of Morriston Hospital.
Medical or nursing members of
the team attend the MDT meet-
ings at Morriston Hospital.
Core membership of the lung cancer MDT in-
cludes a consultant in
palliative medicine who
sees patients as neces-
sary in the multi-profes-
sional lung cancer clinic.
Communication with Primary Care teams
General Practitioners generally refer patients very
promptly when there is a suspicion of lung cancer.
The outcomes of the MDT meetings are com-
municated back by fax to the GP within 24 hours.
All Wales minimum standards
Swansea NHS Trust audits its lung cancer
service annually against the “Lung Cancer Mini-
mum standards”. During 2006/7, there were 46
MDT meetings that were well attended by vari-
ous members of the MDT. At these meetings,
240 patients with a diagnosis of lung cancer were
discussed. The lung cancer clinical nurse specialist
saw 214 of these patients. All general practition-
ers were notifi ed of a diagnosis of lung cancer
(when made) within 24 hours following a patient’s
attendance at Morriston Hospital. Generally,
each patient was provided copies of in-house and
externally produced publications together with
information on self-help and support groups.
The Swansea MDT Team
The Duchess of
Gloucester visiting Ty
Olwen
12
Description of the range of thoracic
procedures offered by
Swansea NHS Trust
A wide range of invasive and minimally
invasive thoracic surgical procedures are pro-
vided at Morriston Hospital. A glossary of
these procedures is provided in Appendix 2.
• Bronchoscopy (rigid or fl exible)
• Mediastinoscopy, mediastinotomy and resection
of mediastinal tumours (neurogenic tumours,
bronchogenic cysts, tumours of the thymus)
• VATS (Video-assisted thoracoscopic surgery)
• Lung or pleural biopsy
• Lung resection (segmentectomy, lobec-
tomy. sleeve resection, pneumonectomy)
• Chest wall resection and reconstruction
• Correction of congenital abnormalities of
the sternum (e.g. pectus excavatum)
• Metastatectomy
• Pleurodesis, pleurectomy and decortication
• Repair of diaphragmatic hernia
• Tracheal surgery and reconstruction
• Surgery for mesothelioma
• Pacing of the diaphragm
• Cervical sympathectomies for hyperhidrosis
Description of facilities for thoracic surgery
There are 5 full-time Consultant Cardiothoracic
Surgeons based in the Cardiac Centre. Mr Mah-
mood Ashour took up his post as locum Con-
sultant Thoracic Surgeon at Morriston Hospital
in January 2006. He has 3 theatre sessions per
week and 5 in-patient beds dedicated to thoracic
patients in addition to the other beds on Cyril
Evans ward that can be used fl exibly. He is sup-
ported by Mr A Youhana who covers his annual
and study leave utilising a combined waiting list.
There are out-patient facilities within the Cardiac
Centre and weekly lung cancer MDT meetings
in Morriston Hospital, West Wales General Hos-
pital and Prince Phillip Hospitals in Carmarthen-
shire. The Cardiac Centre has purchased modern
telemedicine facilities making the clinicians more
accessible to neighbouring hospitals within the
network. Telemedicine conferences are held
fortnightly with Bronglais Hospital in Aberyst-
wyth, weekly with West Wales General Hospital
and Prince Phillip Hospital in Carmarthenshire
and weekly with Singleton Hospital in Swansea.
There is a full range of support services on-
site that includes a respiratory unit led by 2
consultant chest physicians, complemented
by consultant radiologists, histopatholo-
gists and full lung function testing facilities.
Description of MDT arrangements for
lung cancer care in South West Wales
The weekly Lung Cancer MDT and multi-profes-
sional Lung Cancer Clinic are at the forefront of
modern clinical practice and were acknowledged
to be excellent by Dr Martin Muir and Professor
John Dark when they visited Morriston Hospital
in February 2004. The
clinic is attended by
consultant respiratory
physicians, consult-
ant radiologists, a
consultant oncologist,
a consultant cardi-
13
Mr Aprim YouhanaTelemedicine facilities
othoracic surgeon and a palliative care doctor
or nurse. The Clinic is increasingly active as a
Centre for the West Wales Network. The physi-
cal presence of a Consultant Thoracic Surgeon
is of fundamental importance to its function.
The developing South West Wales Lung
Cancer Network is the most advanced and sophis-
ticated of the site-specifi c groups in South West
Wales. Local protocols have been adapted from
the NICE guidance for diagnosis and treatment
and include key roles for thoracic surgery. It has
been accepted by all clinicians in West Wales and
provides equity of access for patients.
This network is now in a strong
position to work with other net-
works in Wales to disseminate best
practice and further improve equity.
Moving towards a
Managed Network
The “Option Appraisal” of 2004
proposed a ”Managed Network” as
one possible solution to the uncer-
tainties regarding the development of
Thoracic Surgical Services in South
Wales. The Thoracic Surgical Service
at Morriston could sit comfortably
within such a network by provid-
ing local services for the population
of West Wales. This is in keeping
with the Welsh Assembly Govern-
ment’s policy of providing healthcare
as close to the patient’s home as
possible. It also allows the Chest Physicians of
West Wales greater access to, and interaction
with, Consultant Thoracic Surgeons on a personal
level. Such access invariably generates greater
options for investigation and treatment of both
malignant and non-malignant thoracic disease.
The isochrone below indicates that Swansea
is strategically placed in the centre of South
Wales such that over two thirds of the popu-
lation of Wales are within 90 minutes of the
Thoracic Unit at Morriston Hospital.
14
Activity Data
Thoracic Surgical procedures 2006-2007
Summary by operation type
Pneumonectomy 14
Lobectomy 37
Bullectomy 15
Repair Of Diaphragmatic Hernia 1
Open Lung Biopsy 13
Pericardectomy 1
Open Pleurectomy 2
Thymectomy 3
Metastatectomy 4
Open Decortication 6
Bronchoscopy 57
Pericardial Biopsy 1
Mediastinal Mass/tumour 9
Thoracotomy 2
Open Pleural Biopsy 14
Mediastinoscopy 12
Repair Of Pectus (Pectoral Flaps) 3
Repair Of Diaphragm & Chest Wall 1
Partial Resection Of Lung 2
Mediastinal Lymphalectomy 2
Mediastinotomy 3
Vats Biopsy & Pleurodesis 2
Vats Lung Biopsy 1
Vats Pleural Biopsy 7
Debridement Of Wound 1
213
Summary By OPCS code
Opcs Code Complex/extra Major/major/
intermediate/minor
Number
E54.1 Complex 14
E54.3 Complex 37
E57.2 Complex 15
E59 Complex 13
E55.1 Complex 6
E54.4 Complex 4
E54.5 Complex 2
K67.1 Complex 1
G23.2 Extra Major 1
B18.1 Extra Major 3
T09.2 Extra Major 14
T07.2 Extra Major 2
T02.1 Extra Major 3
G23.2 Extra Major 1
T03.9 Major 2
E61.4 Major 3
E61.1 Major 9
T85.3 Major 2
K71.1 Major 1
133
E51.1 Intermediate 57
T11.9 Intermediate 2
T11.9 Intermediate 7
T11.2 Intermediate 1
E63.1 Intermediate 12
S57.1 Intermediate 1
80
Total 213
15
Current activity compared with historical activity
Data are presented for the fi nancial years 1998 to 2001 and 2004-7 following resumption of
the thoracic surgical service at Morriston Hospital. The data include all complex, major and in-
termediate cases. Minor procedures (averaging about 50 per year) are not included.
Procedures 1998-1999 1999-2000 2000-2001 2004-2005 2005-2006 2006-2007
Major and intermediate
(non-VATS)
50 110 119 167 114 203
VATS 18 19 25 31 26 10
TOTAL 68 129 144 198 140 213
Thoracic Surgery New
Outpatient Referrals by
LHB - 2006/2007
16
Complications following thoracic surgery
Cardiovascular = 3 (1 post-op MI,
2 re-operation for bleeding)
Pulmonary = 8 (2 collapse/pneumotho-
rax, 1 pneumothorax, 5 “other”)
Renal = 2 (1 H/F dialysis, 1 “other”)
Infective = 3 ( 1 Broncho pleural fi s-
tula, 1 wound infection,1 “other”)
Neurological = 2 (confusion, peripheral nerve injury)
Post op arrhythmias = 9 (all AF/Atrial fl utter/SVT)
Gastrointestinal = 1 (1 “other”)
Average Median
Lung Cancer 10.9 8
Mediastinoscopies 1.5 1
VATS 7.2 5
Bronchoscopies Day case Day case
Mortality
Over the last 5 fi nancial years (2002-2007) there has
been only one death complicating a lung resection
(pneumonectomy) which was caused by an embolus
to the abdomen and leg. This equates to a mortal-
ity rate of ‹1%. The national average for mortality
after lobectomy is 2.6% and pneumonectomy 5-7%,
suggesting excellent early outcomes for patients.
BRIDGENDCARMARTHENSHIRECEREDIGIONGWYNEDDMONMOUTHSHIRENEATH/PORT TALBOTNEWPORTOATSPEMBROKESHIREPOWYSRHONDDA, CYNON TAFFSWANSEATHE VALE OF GLAMORGANTORFAEN
Average and median lengths of stay
During 2006-2007, three patients died dur-
ing their index hospital admission.
One died in the Palliative care unit (Ty Ol-
wen) from metastatic squamous cell car-
cinoma of the lung that had been diag-
nosed following surgical biopsy.
A second died following salvage surgery
for mesothelioma of the pericardium.
A third patient died on the general in-
tensive unit. This patient had under-
gone surgery of her chest (closure of
multiple diaphragmatic perforations) as part of
the treatment of a chyloperitoneum complicat-
ing a laparotomy for intra-peritoneal bleeding.
It is reasonable to conclude that non of these
deaths was related directly to thoracic surgery.
Although the Cardiothoracic Centre at Morriston
Hospital is a relatively new unit, more than 150
lobectomies have been performed. Our results are
consistent with an article published by Treasure
et al (BMJ 2003 327: 73) relating to outcomes
following lobectomy in the UK. Patients who
were operated on by one group of 49 surgeons
with an annual volume of one to 15 lobectomies,
compared well with patients who were operated
on by another group of just six surgeons doing 47
to 96 lobectomies a year. Across the groups of
surgeon activity, the mortality varied from 2.0%
to 2.9%, with no evidence of relation to volume.
17The Cardiac Centre Morriston Hospital
Predicted future demand modelling
Assumptions
Assuming that current estimates for the inci-
dence of lung cancer in Wales is approximately
2000 per annum and aiming for a resection rate
of 15%, there should be 1700 lung cancer cases
in South Wales and therefore 250-300 resec-
tions per annum for lung cancer alone. In addi-
tion, there will be a requirement for other major
thoracic surgical procedures such as resection
of mediastinal, chest wall and tracheal tumours
together with decortication for empyema.
The most reliable fi gures for the incidence of
cancer in South West Wales relates to breast
cancer. There are approximately 650 new cases
per annum. The incidence of breast cancer in
the UK is 40,000 per annum and broadly similar
to that of lung cancer (38,000 per annum). As-
suming the network coverage has an incidence
similar to the UK, it is estimated that the South
Wales Lung Cancer Network should be diagnos-
ing and treating approximately 600 cases per
annum by curative resection. Again a resection
rate of 15% would suggest 110-130 cases per an-
num for West Wales alone.
New scanning techniques
Tumour type and disease staging determine
whether surgical resection is feasible. The most
accurate predictor of long-term survival in early
lung cancer is the disease stage and those tu-
mours that are more peripherally placed are
easier to remove than those placed centrally
Positron Emission Tomography (PET)
Fluorodeoxyglucose (FDG) - PET scanning is a
sensitive method to distinguish spread of malignant
cells to lymph nodes from those where enlarged
lymph nodes are reactive rather than infi ltrated
by tumour. Its use helps to guide physicians and
surgeons in the selection of patients suitable or
unsuitable for curative resection. For example,
it should reduce the number of cases of thoracic
surgery that are abandoned due to previously
undetected lymph node involvement but increase
resection rates in those who may otherwise be
turned down because of apparent lymph node in-
volvement that represented reactive changes only.
Magnetic Resonance Imaging (MRI)
MRI (as opposed to X-ray computed tomography)
further refi nes the identifi cation
of resectable thoracic tumours
particularly with chest wall and
mediastinal invasion. Imaging is
immediately available to physi-
cians and surgeons on site.
18Contrast MRI
19
Theatre/bed capacity in
cardiothoracic centre
The Cardiothoracic Unit has adopted modern
practices to deliver high levels of cardiology and
cardiothoracic surgical activity through the unit.
The unit has only 62 beds of which 8 are coronary
care beds, 8 are intensive care beds and 8 are high-
dependency beds. The fl exible use of these beds
has enabled the Centre to perform approximately
2100 coronary angiograms, 1000 angioplasties, 350
permanent pacemaker implantations and 750 car-
diac surgical operations and more than 200 tho-
racic surgical procedures annually. The addition of
5 new beds (located in the former cardiology
day case) to the surgical ward will enable the
thoracic activity to increase signifi cantly with-
out any need for further capital investment.
Appointment of a second Consultant Thoracic Surgeon
Benefi ts of appointment
Service benefi ts
Historically, thoracic surgery has been undertaken
by consultants with dual training in cardiac and
thoracic surgery. With the development of an
NSF for coronary artery disease, the adoption
of the European Working Time Directive and the
new amended Consultant Contract in Wales, it is
diffi cult for cardiothoracic consultants to commit
energies to both disciplines. In addition, the need
to achieve access targets for cardiac surgery has
meant that patients requiring thoracic surgery
have been “competing” for similar resources.
The appointment of a dedicated thoracic surgeon
has enabled the service to be placed on a proper
foundation. Mr Ashour has been able to focus
his energies to the delivery and expansion of an
already existing high quality service for the resi-
dents in South West Wales. There is a dedicated
out-patient clinic and 4 MDT meetings each week
(in Swansea and Carmarthen) and the accessibility
of a standalone thoracic surgeon locally provides
support to the Respiratory Physicians and other
clinicians in the network. Mr Ashour has raised
awareness of thoracic services (e.g. lung resection
for cancer) to primary and secondary care beyond
their current levels. However, Mr Ashour has the
benefi t of working in a Specialist Cardiothoracic
Centre with high quality facilities and receives sup-
port from cardiac sur-
gical colleagues who
are trained in thoracic
surgery (e.g. for peri-
ods of annual leave and
for the on-call rota).
The incidence of lung cancer in South West Wales
combined with the challenging access targets
for cancer treatment (maximum of 62 days from
referral with suspected cancer to defi nitive treat-
ment) means that it is not possible for a single
thoracic surgeon to fulfi l the surgical demands
for lung cancer treatment. To consolidate the
service, the Trust is planning to appoint a further
substantive thoracic surgeon. This will ensure
continuity of the service as also provide an en-
hanced infrastructure for teaching and training.
Teaching and Training
Specialist Registrars in Cardiothoracic Surgery
have regular academic teaching and practical train-
ing (in theatre) in all aspects of Thoracic Surgery.
The consultants have a keen desire to teach and
a strong track record in doing so. There is a
monthly training day for Morriston, UHW and
Bristol SpRs. The appointment of a dedicated
thoracic surgical consultant has enhanced training
opportunities within the Trust. Morriston Hospital
is the only hospital in Wales where SpRs in Tho-
racic Medicine have the opportunity to observe
surgical procedures on site. Undergraduates
based at the School of Medicine, Swansea have the
opportunity to follow from diagnosis to treat-
ment in cases such as empyema and lung cancer.
20Mr Ashour, Consultant Thoracic Surgeon
ConclusionsDespite 10 years of uncertainty, the enthusiasm
and drive to develop Thoracic Surgery at Mor-
riston Hospital continues unabated. For patients
with lung cancer, resection rates have increased
signifi cantly (from 5% to 15%) since the appoint-
ment of a dedicated thoracic surgeon. The
provision of locally-based thoracic surgical services
within a Managed Network is the best way to pro-
vide the appropriate quality of care that the popu-
lation of South Wales should expect to receive.
Swansea NHS Trust continues to view Thoracic
Surgery as an important component of the port-
folio of services that it offers to the population
of Swansea and South West Wales. Patients from
West Wales have historically had poor access to
thoracic surgical services in Llandough Hospital
and Bristol and the geographic distance to these
centres makes it diffi culty for them to receive
support from their friends and families when they
need it most. Much of the patient’s care is deliv-
ered at primary and secondary care level and an
integrated approach to the management of the
patient pathway is required. Thoracic surgery
complements other key services offered by the
Trust such as the Trauma Centre, plastic surgery
for major chest wall resection and reconstruction,
oesophageal and maxillofacial surgery (and visit-
ing ENT surgery) for Tracheal surgery. Previous
surveys of chest physicians have highlighted that
the “existing level of provision of thoracic surgery”
in South Wales “did not meet their requirements”
and they “would be prepared to refer thoracic
cases to Morriston Hospital”. The Royal Col-
lege of Surgeons state that cardiac and thoracic
surgery should be provided on the same site.
There is overwhelming support for contin-
ued and enhanced Thoracic Surgical Services
from the South West Wales Lung Cancer Net-
work, all Chest Physicians and Cardiotho-
racic Surgeons in South West Wales as well
as the local population and media.
21Lung Function Suite Morriston Hospital
Thoracic Surgery Satisfaction SurveysDuring the spring of 2007, the Thoracic Surgical Department arranged for a survey of the users of the tho-
racic surgical service to be undertaken. Paper questionnaires were sent to the last 30 patients who had
used the service as well as 12 consultants who referred patients to the thoracic surgical service. 25 and
11 anonymous replies were received respectively. The responses are detailed on the next two pages.
In summary;
Of the patients who have used the service, 96% rated their overall experi-
ence of the thoracic surgical service at Swansea as being excellent or good.
Of the consultants who have used the service, 90% rated the overall treat-
ment that their patients received as being excellent or good.
22
23
Q1 Are you?
Male …………………………………..… 80.0% Female …………………………………..20.0%
Q8 Were you given a likely date for your operation at the consultation?
Yes ………………………………….88.0% No ……………………………....…..12.0%
Q2 What age bracket are you in? 18-30 years ……………………….……....4.0% 31-50 years …………………….…….….20.0%
51-70 years ……………………….……..48.0% Over 71 years …………………….……..28.0%
Q3 Who referred you to the Thoracic Surgery Unit in Swansea?
Your hospital consultant……………….96.0% Your GP ………………………………….0.0% Other …………………………………….4.0%
Q9 How would you describe the care provided by: Excellent Good Fair Poor Thoracic Surgical 88.0% 12.0% 0.0% 0.0% Consultant
Medical Staff 80.0% 16.0% 0.0% 0.0%
Nurses 80.0% 20.0% 0.0% 0.0%
Physiotherapist 48.0% 28.0% 4.0% 4.0%
Other 48.0% 12.0% 0.0% 4.0%
Q4 How long did you wait before being seen in the Thoracic Surgical Clinic at Swansea?
I was seen within 1-2 weeks ……..……..12.0% I was seen within 2-3 weeks ………..…..60.0% I waited over 4 weeks ……………….…..28.0%
Q5 Were you given any written information before or during your consultation at the Thoracic Surgical Clinic ?
Yes ………………………………….52.0% No ……………………………....…..44.0%
Q6 Did you have the opportunity to ask questions Before or during your consultation at the Thoracic Surgical Clinic?
Yes ………………………………….92.0% No ……………………………....…..4.0%
Q10 How would you rate the follow up and after care you Received from the Thoracic Surgical Service in Swansea?
Excellent…………………………….……………..60.0%
Good ………………………………….……………36.0% Fair ………………………………….………………0.0%
Poor …………………………….…………………..4.0%
Q11 Overall, how would you rate the experience at the Thoracic Surgical Service at Swansea?
Excellent…………………………….……………..60.0%
Good ………………………………….……………36.0% Fair ………………………………….………………4.0%
Poor …………………………….…………………..0.0%
Q7 What was your first impression of the Thoracic Surgical Service provided in Swansea?
Excellent……………………..……..76.0% Good ………………………….……20.00% Fair …………………………….…….4.0% Poor …………………………….…...0.0%
Q12 Do you have any suggestions or other comments to Improve the Thoracic Surgical Service at Swansea?
Yes ………………………………….24.0% No ……………………………....…..76.0%
Free text comments to Q12 “Do you have any suggestions or other comments to improve the Thoracic Surgical Service at Swansea?” “Quality of food after operation could be improved” “More Nurses” “Post operative care excellent in HDU” “Low staffing levels on ward” “Lack of toilet facilities and proper functioning showers” “Expression of thanks to Staff” “More written information” “Follow-up treatment could be improved”
Patients who have used the service
Referrers to the Swansea Thoracic Surgical Service
About you Q4 How would you rate the overall treatment your patient received?
Q1 Are you?
Referring Consultant…………………….… 100.0% G.P. ………………………………………..…0.0% Other ……………………………………..…...0.0%
0.0%
Excellent …………………….80.0% Good …………………………10.0% Fair …………………………..10.0% Poor ……………………………0.0%
Q2 Why did you refer the patient to the Swansea Thoracic Surgical Service? (tick all that apply)
Professional recommendation ……….…60.0% Good reputation ………………………….80.0% Nearest referral centre ………..………100.0%
Satisfied with previous service ……...…70.0%
Good quality care …………………..……70.0%
Good communication ………………...….70.0%
Good patient outcomes ………………….70.0%
Good patient satisfaction …………….….60.0%
Other (please state) …………………..…20.0%
Q5 Did you receive timely information following your patient’s discharge from hospital?
Yes ……………………………..80.0%
No. …………………………..…20.0%
Q6 When you received this information would you categorise it as?
Excellent ………………………...80.0% Good ……………………………..20.0% Fair …………………………………0.0% Poor ………………………………..0.0%
Q3 How did you find the response to your referral in the Swansea Thoracic Surgical Service?
Excellent …………………………………….80.0% Good …………………………………………10.0% Fair ……………………………………… …10.0% Poor ……………………………………… ….0.0%
Q7 Do you have any suggestions to improve the service?
Yes ………………………………..70.0%
No………………………………….30.0%
BRIEF OVERVIEW OF SURVEY COMMENTS FROM REFERS TO THE SERVICE Free text comments to Q7 “Do you have any suggestions to improve the Service?” “Mr Ashour requires support to cover leave” “Patients should be able to see the Surgeon more quickly” “More operating time required” “Service excellent” “Increase number of Surgeons” “Increase number of theatre sessions”
GlossaryBronchoscopy
Rigid bronchoscopy: A rigid bronchoscope is a
straight, hollow, metal tube. Rigid bronchos-
copy is performed less often now that fl ex-
ible bronchoscopy is routinely available, but it
remains the procedure of choice for removing
foreign material and for several other treat-
ments. Rigid bronchoscopy also becomes useful
when bleeding interferes with seeing the area.
Flexible bronchoscopy: A fl exible bronchoscope
is a long thin tube that contains small clear fi bres
that transmit light images as the tube bends. Its
fl exibility allows this instrument to reach the
farthest points in an airway. The procedure can be
performed easily and safely under local anaesthesia.
Bullectomy
Bullae are formed in the lung when alveoli
rupture and combine with other alveoli to
form one alveolus. This causes a reduc-
tion in respiratory capacity and they can be
resected via a thoracotomy approach.
Chest wall resection
Major resection of the chest wall is occasionally
necessary in the treatment of malignant disease.
Small resections are usually tolerated without
requiring the reconstruction of the rigid tho-
racic cage. The extent of the resection and what
it involves will be dependent on the severity of
the disease. It is usually performed via a thora-
cotomy incision.
Chest wall re-
construction
If a major chest wall
resection has been
performed, the chest
wall may need to be reconstructed to maintain a
rigid thoracic cage. This usually requires a sand-
wich of polypropylene mesh and methyl meth-
acrylate glue. This is constructed and allowed
to solidify outside the body and then sutured
into place or it may be formed within the defect
to be reconstructed. Large defects may also be
repaired with muscle or myocutaneous fl aps.
Muscles that can be used are the pectoralis major,
serratus, latissimus dorsi or the rectus muscle.
They may then be covered by skin grafts, if re-
quired. These procedures require the skills and
expertise of plastic and reconstructive surgeons.
Endobronchial therapies
Endobronchial therapies, including, brachytherapy,
stenting, laser therapy, cryotherapy, and dia-
thermy. Stents are used to keep compromised
large airways open in a variety of malignant and
benign conditions. Diathermy resection is per-
formed via a rigid bronchoscope and diathermy
is used to resect and cauterise intraluminal tu-
mours to relieve breathlessness and haemoptysis.
Lobectomy
The lungs are divided into separate sections or
“lobes.” The left lung has two lobes and the right
lung has three lobes. During a lobectomy a sur-
geon will remove an entire lobe of a patient’s lung.
Lung volume reduction surgery
Lung volume reduction surgery is a surgical proce-
dure where the worst areas of damaged lung tis-
sue (usually due to emphysema) are removed. This
surgery can be performed by either median ster-
notomy or video-assisted thoracoscopic technique.
The goal of the surgery, with either operative
technique, is to remove up to 30 % of the lung
volume and therefore make the lungs smaller.25
Median Sternotomy
This is an incision in which the sternum (or breast-
bone) is divided down the middle from top to bot-
tom and is routinely used to access the heart and
mediastinum but is also very useful for bilateral
lung procedures such as lung volume reduction
surgery or combined cardiac and lung operations.
Mediastinoscopy
This is a procedure in which a tube is inserted
into the chest to view the organs in the area
between the lungs and nearby lymph nodes.
The tube is inserted through an incision above
the breastbone. This procedure is usually per-
formed to get a tissue sample from the lymph
nodes on the right side of the chest and is
very important for staging of lung cancer.
Mediastinotomy
This is a procedure in which an incision is
made on one side of the breastbone so the
physician can view organs of the mediastinum
that cannot be seen by mediastinoscopy
Metastatectomy
This is the excision of metastatic nodules from
areas of the lung. It can involve a small number
of nodules or can be multiple. It is performed
via a thoracotomy if one side is affected or a
sternotomy for bilateral metastatectomy.
Open lung biopsy
Open lung biopsy is a test in which a small piece
of the lung tissue is removed through a surgical
incision in the chest. The sample is then ex-
amined for cancer, infection, or lung diseases.
Pacing of the diaphragm
Patients who have sustained injuries to the high
spinal cord that affects the nerve supply to the
diaphragm may develop respiratory distress ow-
ing to paralysis of the diaphragm. This can be
ameliorated by the technique of diaphragmatic
pacing. A pacemaker device is implanted under
the skin and electrodes attached to the phrenic
nerve (the nerve supply to the diaphragm).
Pancoast tumour and Grunwald procedure
This is a tumour of the extreme apex of the
lung. It may involve invasion of the parietal
pleura, brachial plexus, chest wall, fascia at the
root of the neck, subclavian vein and artery
and the sympathetic chain. The Grunwald pro-
cedure refers to the extensive neck incision,
with or without a thoracotomy that may be
required to access and resect the tumour.
Pleurectomy
Pleurectomy is the surgical procedure to remove
the parietal pleura, the outermost lining around
the lungs. This procedure is performed for a
variety of disorders including pleural effusion,
malignant pleural mesothelioma, and trauma.
Pleurodesis
Pleurodesis is the artifi cial obliteration of
the pleural space. It is done to prevent re-
currence of pneumothorax or pleural effu-
sion. It can be done chemically or surgically.
Pneumonectomy
This is the removal of an entire lung,
for cancer, lung abscesses, bronchiecta-
sis, or extensive tuberculosis.
Rib resection
This is the removal of part or the whole rib for
disease or to obtain access to a specifi c area of
lung. It can also be
done to obtain rib
for bone grafting.
Segmentectomy
This is performed
to resect small tu-
26
mours in a segment of a lobe. It is preferred to
a lobectomy in patients with borderline pulmo-
nary status to preserve some lung function.
Sleeve resection
This is usually performed when an upper lobe is
removed with a circumferential cuff of the parent
bronchus. Continuity to the remaining lobe or
lobes is restored by an end-to-end anastamosis.
Sternal deformity correction
(e.g. pectus excavatum)
Pectus Excavatum is a congenital deformity that
causes the sternum to be depressed into the chest
causing a “caved-in” look. It causes decreased
lung capacity and often chest and back pain. This
condition occurs once in every 500 children,
normally in males. The condition often becomes
worse during the teenage years. Surgical cor-
rection can be undertaken to improve cosmetic
appearance and to improve respiratory function.
Thoracotomy
Thoracotomy is a surgical incision into the chest.
It is performed by a surgeon to gain access to
the thoracic organs most commonly the heart,
the lungs, the oesophagus, or the thoracic aorta.
Thymectomy
A thymectomy is an operation to re-
move the thymus gland. It usually results
in remission of myasthenia gravis with the
help of medication including steroids
Tracheal resection
Trauma, tracheostomy and prolonged endotra-
cheal intubation are the usual causes of benign
strictures of the trachea that may require resec-
tion. Also, malignant tumours of the trachea
may cause obstruction and require resection.
Video Assisted Thoracoscopic Surgery (VATS)
This is an advanced, minimally invasive surgi-
cal procedure used for both diagnosis and
treatment of lung cancer. Instead of mak-
ing a large incision through the chest wall, the
surgeon makes two or three small incisions
through which a tiny camera and surgical instru-
ments are introduced, and tissue removed.
27